Log In
Print
BCIQ
Print
Print this Print this
 

Dengue fever vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionAttenuated tetravalent vaccine against dengue fever
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationDengue fever
Indication DetailsPrevent dengue fever
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today